Navigation Links
HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
Date:4/10/2012

Levanger, Norway and Boulder, CO, USA -- April 10, 2012 -- HUNT Biosciences and SomaLogic, Inc., today announced a new collaboration to advance the clinical use of protein biomarkers, with an initial focus on the validation of biomarkers for the prediction of cardiovascular events such as strokes, heart attacks, and heart failure.

The collaboration will analyze biological samples and clinical data from HUNT Biosciences using SomaLogic's unique SOMAscan proteomic technology. HUNT Biosciences will work with SomaLogic to select and supply samples and accompanying clinical data and selected phenotype information from up to 2000 of the more than 100 000 participants in the large HUNT health study.

"We believe the HUNT health study offers samples and data that will help identify and validate protein biomarkers of high clinical significance," said Dr. Per A. Foss, CEO of HUNT Biosciences. "SomaLogic has a promising technology and the company shares our vision of the importance of biomarkers to improve healthcare. We believe this collaboration has a significant potential and could be extended to include other medical conditions that will benefit from the discovery and use of well-documented biomarkers".

"We are delighted to work with HUNT biosciences to develop new diagnostic tools that predict cardiovascular risk," said Stephen Williams, Chief Medical Officer of SomaLogic. "The clinical sample cohort available through the HUNT health study is among the broadest in the world, and we believe that our technology is uniquely capable of deriving new clinical insights from those samples that can lead to new diagnostics and acceleration of drug discovery and development efforts to the benefit of patients everywhere."


'/>"/>

Contact: Fintan R. Steele, Ph.D.
fsteele@somalogic.com
720-214-3080
SomaLogic, Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. TGen Drug Development recognized for economic development of Arizona biosciences
2. BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
3. Stanford professor honored for contributions to computational biosciences
4. Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute
5. Avantra Biosciences teams with TGen Drug Development to assist pharma
6. Human cells can copy not only DNA, but also RNA, says team from Pitt, Helicos BioSciences
7. InQ Biosciences Introduces First Fully Integrated Cell Research System
8. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
9. SomaLogic Inc. receives Grand Challenges tuberculosis biomarkers grant
10. SomaLogic and Ambergen announce agreement for commercial applications of photocleavable biotin
11. SomaLogic announces agreement with leading global pharma company to accelerate R&D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... BOSTON (PRWEB) , ... June 16, 2020 , ... The ... Ph.D., is betting that if the stem cell medicine and pharmaceutical industries have easier ... their practice. So, starting July 5 of this year, Independence Day weekend in ...
(Date:6/11/2020)... , ... June 09, 2020 , ... Superior Controls, ... industrial automation and IT solutions for the life sciences industry, is pleased to announce ... Development working out of the company’s Seabrook, New Hampshire office. In his new ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... for enterprises globally, has collaborated with EchoNous Inc. to develop the cloud-based connected ... measure systolic heart function, which has been clinically tested versus expert measurements, yielding ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech ... Regulatory Solutions, in a one hour live webinar on Thursday, August 13, ... China for drugs and medical devices. Specifically, for medical devices, the NMPA has departments ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
Breaking Biology Technology: